Maartmann-Moe K, Berg-Johnsen P
Clin Genet. 1981 Aug;20(2):90-103.
Six indices of low density lipoprotein (LDL) receptor activity were assayed in cultured fibroblasts from seven subjects with familial hypercholesterolemia (HC) and six subjects without HC (non-HCs). Four non-HCs, three HC heterozygotes and one HC homozygous proband belonged to one kindred (kindred A). The proband's fibroblast 125I-LDL processing values fell within or were slightly above the range defined by fibroblasts from three "receptor-negative" HC homozygotes. Thus, the plasma membrane receptor defect in this kindred is probably of the "receptor-negative" category. LDL receptor-dependent 125I-LDL processing was about twice as high in fibroblasts from non-HCs as in those from HC heterozygotes belonging to kindred A. The segregation pattern of LDL receptor activity in this kindred was compatible with control by a single gene locus. 125I-LDL processing values from non-HCs, HC heterozygotes and HC homozygotes differed significantly from one another, but non-HCs and HC heterozygotes showed some overlap. LDL receptor-dependent 125I-LDL association (plasma membrane binding plus intracellular accumulation) data for 6 HC heterozygous and 13 non-HC fibroblast strains clustered into two and into three groups, respectively. Median 125I-LDL association levels in these groups appeared to be in agreement with hypothesis that two different geno-types in HC heterozygotes and three in non-HCs determined LDL receptor activity. These findings suggest the possibility that 125I-LDL processing studies may reveal "normal" alleles at the LDL receptor locus.
在来自7例家族性高胆固醇血症(HC)患者和6例非HC患者(非HC者)的培养成纤维细胞中检测了六个低密度脂蛋白(LDL)受体活性指标。4例非HC者、3例HC杂合子和1例HC纯合先证者属于一个家系(家系A)。先证者的成纤维细胞125I-LDL处理值落在或略高于由3例“受体阴性”HC纯合子的成纤维细胞所定义的范围。因此,该家系的质膜受体缺陷可能属于“受体阴性”类型。来自非HC者的成纤维细胞中依赖LDL受体的125I-LDL处理量约为来自家系A的HC杂合子的两倍。该家系中LDL受体活性的分离模式与由单个基因座控制相符。非HC者、HC杂合子和HC纯合子的125I-LDL处理值彼此有显著差异,但非HC者和HC杂合子有一些重叠。6例HC杂合子和13例非HC成纤维细胞株的依赖LDL受体的125I-LDL结合(质膜结合加细胞内积累)数据分别聚为两组和三组。这些组中的125I-LDL结合水平中位数似乎与以下假设一致,即HC杂合子中有两种不同基因型,非HC者中有三种基因型决定LDL受体活性。这些发现提示125I-LDL处理研究可能揭示LDL受体基因座处“正常”等位基因的可能性。